Homocysteine and cardiovascular risk;Homocystéine et risque cardiovasculaire

Sang Thrombose Vaisseaux

Volumn 19, Issue 3, 2007, Pages 143-149

  Vesin, Claire ^a   Horellou, Marie Hélène ^b   Mairesse, Sandrine ^a   Conard, Jacqueline ^b   Safar, Michel ^a   Blacher, Jacques ^a  

^a Unité HTA   (France)

^b HÔTEL DIEU   (France)

Author keywords

Atherosclerosis; Homocysteine; Hyperhomocysteinemia; Vitamin supplementation

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXINE; VITAMIN B GROUP;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEMENTIA; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SHORT SURVEY; STROKE; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 34247181313     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: 10.1684/stv.2007.0069     Document Type: Short Survey

References (20)

1. Blacher J, Czernichow S, Horellou MH, et al. Homocystéine, acide folique, vitamines du groupe B, et risque cardiovasculaire. Arch Mal Cœur Vaiss 2005 ; 98 : 145-52.
2. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid basedsupplements meta-analysis of randomized trials. Br Med J 1998 ; 316 : 894-8.
3. McCully KS. Vascular pathology of homocysteinemia : implications for the pathogenesis of arterosclerosis. Am J Pathol 1969 ; 56 : 111-2.
4. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease : a common mutation in methylene tetrahydrofolate reductase. Nat Genet 1995 ; 10 : 111-3.
5. Pfeiffer GM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification : results from the National Health and Nutrition Examination Survey 1999-2000. Am J Nutr 2005 ; 82 : 442-50.
6. Clarke R, Grimley Evans J, Schneede J, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004 ; 33 : 34-41.
7. Malinow MR, Bostom AG, Krauss RM. Homocysteine, diet and cardiovascular diseases. A statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 1999 ; 99 : 178-82.
8. Clarke R. Vitamin B12, folic acid and the prevention of dementia. N Engl J Med 2006 ; 354 : 2817-9.
9. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis : a meta-analysis of published epidemiological studies. J Thromb Haemost 2005 ; 3 : 292-9.
10. Homocystein Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke : 6000 events in 30 observational studies. JAMA 2002 ; 288 : 2015-22.
11. Tsai JC, Perrela MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine : a link to atherosclerosis. Proc Natl Acad Sci USA 1994 ; 91 : 6369-73.
12. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002 ; 346 : 476-83.
13. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998 ; 55 : 1449-55.
14. Schnyder G, Roffi M, Flammer Y, PinR, Hess OM. Effect of homocystein-lowering therapy with folic acid, vitamin B12 and vitamin B6, on clinical outcome after percuaneous coronary intervention. The Swiss Heart Study : a randomized controlled trial. JAMA 2002 ; 288 : 973-9.
15. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006 ; 354 : 1567-77.
16. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006 ; 354(15) : 1578-88.
17. The WAFACS study. Late breaking clinical trials. Albert CM. AHA, 2006.
18. Mcmahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A Controlled Trial of Homocysteine Lowering and Cognitive Performance. N Engl J Med 2006 ; 354 : 2764-72.
19. Zoungas S, McGrath BP, Branley P, et al. Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure. J Am Coll Cardiol 2006 ; 47 : 1108-16.
20. den Heijer M, Willems HPJ, Blom HJ, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep-vein thrombosis and pulmonary embolism. A randomized, placebo-controlled, double blind trial. Blood. 2006.